ACADIA Pharmaceuticals Debt
| ACAD Stock | USD 17.57 0.05 0.29% |
ACADIA Pharmaceuticals holds a debt-to-equity ratio of 0.146. At present, ACADIA Pharmaceuticals' Short Term Debt is projected to increase significantly based on the last few years of reporting. The current year's Net Debt To EBITDA is expected to grow to 1.83, whereas Interest Debt Per Share is forecasted to decline to 0.38. . ACADIA Pharmaceuticals' financial risk is the risk to ACADIA Pharmaceuticals stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
ACADIA Pharmaceuticals' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. ACADIA Pharmaceuticals' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps ACADIA Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect ACADIA Pharmaceuticals' stakeholders.
For most companies, including ACADIA Pharmaceuticals, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for ACADIA Pharmaceuticals, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, ACADIA Pharmaceuticals' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
At present, ACADIA Pharmaceuticals' Non Current Liabilities Total is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 307 M, whereas Non Current Liabilities Other is forecasted to decline to about 12.7 M. ACADIA |
ACADIA Pharmaceuticals Bond Ratings
ACADIA Pharmaceuticals financial ratings play a critical role in determining how much ACADIA Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ACADIA Pharmaceuticals' borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (2.87) | Unlikely Manipulator | View |
ACADIA Pharmaceuticals Debt to Cash Allocation
Many companies such as ACADIA Pharmaceuticals, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
ACADIA Pharmaceuticals currently holds 57.2 M in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. ACADIA Pharmaceuticals has a current ratio of 4.44, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ACADIA Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.ACADIA Pharmaceuticals Total Assets Over Time
ACADIA Pharmaceuticals Assets Financed by Debt
The debt-to-assets ratio shows the degree to which ACADIA Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.ACADIA Pharmaceuticals Debt Ratio | 8.27 |
ACADIA Pharmaceuticals Corporate Bonds Issued
Most ACADIA bonds can be classified according to their maturity, which is the date when ACADIA Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ACADIA Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning ACADIA Pharmaceuticals Use of Financial Leverage
ACADIA Pharmaceuticals' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures ACADIA Pharmaceuticals' total debt position, including all outstanding debt obligations, and compares it with ACADIA Pharmaceuticals' equity. Financial leverage can amplify the potential profits to ACADIA Pharmaceuticals' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if ACADIA Pharmaceuticals is unable to cover its debt costs.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 65.8 M | 69.1 M | |
| Net Debt | -118.3 M | -112.4 M | |
| Short Term Debt | 10.8 M | 11.4 M | |
| Net Debt To EBITDA | 1.74 | 1.83 | |
| Debt To Equity | 0.12 | 0.13 | |
| Interest Debt Per Share | 0.40 | 0.38 | |
| Debt To Assets | 0.09 | 0.08 | |
| Long Term Debt To Capitalization | 0.08 | 0.05 | |
| Total Debt To Capitalization | 0.12 | 0.11 | |
| Debt Equity Ratio | 0.12 | 0.13 | |
| Debt Ratio | 0.09 | 0.08 | |
| Cash Flow To Debt Ratio | 0.34 | 0.35 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out the analysis of ACADIA Pharmaceuticals Fundamentals Over Time. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 28.347 | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth 0.183 | Return On Assets |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.